The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy

E-ISSN： 1873-4286|10|15|1739-1744

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.15, 2004-06, pp. : 1739-1744

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis

By Ulanova Marina Duta Florentina Puttagunta Lakshmi Schreiber Alan D Befus A Dean

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 901-921

Informa Healthcare

Access to resources Recommend Favorite

Structure-based Drugs Design Studies on Spleen Tyrosine Kinase Inhibitors

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 845-858

Bentham Science Publishers

Access to resources Recommend Favorite

A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

By Garcia Jorge A. Hudes Gary R. Choueiri Toni K. Stadler Walter M. Wood Laura S. Gurtler Jayne Bhatia Shailender Joshi Adarsh Hozak Rebecca R. Xu Yihuan Schwartz Jonathan D. Thompson John A.

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1647-1655

Blackwell Publishing

Access to resources Recommend Favorite

Cheminfomatic-based Drug Discovery of Human Tyrosine Kinase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1452-1462

Bentham Science Publishers

Access to resources Recommend Favorite

Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 – 2013

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 573-595

Informa Healthcare

Access to resources Recommend Favorite